Articles Posted in Uncategorized

On this page, our product liability lawyers explain who is potentially eligible to file a Paraquat lawsuit based on the current criteria that our firm is using to screen potential Paraquat cases. We will also discuss the potential settlement value of Paraquat lawsuits and what information Paraquat plaintiffs must provide in the class action MDL.

About the Paraquat Lawsuits

Paraquat is very strong industrial herbicide that is used in commercial farming across the U.S. Paraquat is actually illegal in most countries, but in the U.S. licensed farmers can buy it. Paraquat is manufactured by Syngenta, a global agro chemical company headquartered in Switzerland. In the U.S., Paraquat is usually sold under the brand name Gramoxone.

On this page, we will look at who qualifies to file a Suboxone tooth decay lawsuit. We will summarize the basic eligibility criteria that our firm is applying to screen potential Suboxone lawsuits, and we will describe the relevant injuries associated with the Suboxone lawsuits.

About the Suboxone Lawsuits

Suboxone is a prescription drug that is commonly used for the treatment of opioid addiction recovery. There is overwhelming evidence showing that Suboxone causes chronic dry mouth which can lead to acute tooth decay and tooth loss. The manufacturers of Suboxone were aware of this side effect for more than a decade but failed to include any warning about tooth decay on the drug product label.

If you’ve undergone Tepezza treatment for an eye condition and experienced subsequent hearing issues like hearing loss or ringing in the ears (tinnitus), you might have grounds for a lawsuit and get financial compensation. Tepezza, a recently approved drug for thyroid eye disease treatment, has been shown to cause permanent hearing loss in some patients.

Those who received Tepezza and suffered hearing damage are now pursuing product liability lawsuits. Our legal team is actively pursuing cases related to Tepezza-induced hearing impairment across all 50 states. Reach out to us today at 800-322-3010 to determine if your situation qualifies.

UPDATES:

Lawsuits are being filed across the U.S. claiming that cow-milk based baby formula has caused many premature infants to develop a serious gastrointestinal infection called necrotizing enterocolitis (NEC). The basis for these lawsuits is that research has long shown that cow milk is associated with NEC in premature infants, and the manufacturers of formulas such as Similac and Enfamil should have warned doctors and parents of the risks. Our firm is currently seeking NEC formula lawsuits.  Plaintiffs who bring successful baby formula NEC lawsuit could receive significant financial compensation. 

Formula Can Cause Increased Risk of NEC in Premature Infants 

Infant formula products such as Similac or Enfamil are made from cow milk and given to newborn babies as a substitute for human breast milk.  A growing body of scientific evidence has proven cow milk formulas significantly increase the risk of a life-threatening bowel infection called necrotizing enterocolitis (NEC) when given to premature infants. 

Recent studies have established that prolonged use or exposure to the industrial herbicide paraquat (Grameoxone) can lead to the development of early-onset Parkinson’s disease. Now thousands of agriculture workers are filing paraquat lawsuits alleging that they developed Parkinson’s due to occupational exposure to paraquat.

The paraquat cases have been consolidated into a “class action” MDL which should eventually results in a global settlement with payments to all claimants. This post will look at how much settlement compensation paraquat plaintiffs might reasonably expect to get.

Related Paraquat Posts

Warfarin is an anticoagulant medication commonly used to prevent blood clots and stroke in individuals with certain medical conditions such as atrial fibrillation, heart valve replacement, and deep vein thrombosis. It works by blocking the production of certain clotting factors in the blood. Warfarin is one of the most widely prescribed anticoagulants and has been in use for over 60 years.

This page looks at Warfarin side effects and litigation that has surrounded this medication.

• Eliquis side effects

Our lawyers are investigating toxic baby food autism lawsuits.

What triggered our involvement in these cases was a congressional investigation last year that revealed that many popular brands of baby foods in the U.S. contain dangerously high levels of toxic heavy metals such as lead, mercury, and arsenic. Scientific evidence and studies have shown that consumption of these metals during infancy and early childhood can cause neurologic damage and autism.

Product liability lawsuits are now being filed nationwide against baby food manufacturers. These baby food autism lawsuits allege that the manufacturers knowingly sold their products with unsafe levels of toxic metals and that the plaintiffs developed autism spectrum disorders from consuming them in their baby foods.

Nexium, or esomeprazole, is a drug that is used to treat heartburn and excessive amounts of acid in the stomach. Specifically, it is used to treat duodenal and gastric ulcers, esophagitis, gastroesophageal reflux disease (GERD), and Zollinger-Ellison syndrome. Nexium is a proton pump inhibitor (PPI) that decreases the amount of acid produced in the stomach. Other drugs that are in the same class as Nexium include Prevacid and Prilosec. Approximately 15 million Americans use PPIs that are sold both as prescription and over-the-counter. Nexium sales exceed $3 billion a year.

Nexium Class Action Lawsuit Updates 

October 2023: AstraZeneca agreed to a $425 million settlement to resolve approximately 11,000 lawsuits related to Nexium and Prilosec. This settlement addresses claims that long-term use of these proton pump inhibitors led to kidney injuries, including chronic kidney disease and renal failure. The settlement was announced shortly before the first bellwether trial was scheduled to begin on October 10, 2023.

March 2023: The bellwether trial in the Nexium PPI litigation that was supposed to get started this month has now been postponed to June 5, 2023. Two additional bellwether trials will follow in July and September. No explanation for the postponement was given, but many believe that was done because the parties are close to a settlement. 

August 2022:  Defendants in the PPI MDL had moved to dismiss all failure to warn claims in the PPI class action lawsuit because they are preempted. The argument, and it is a weak one, is that because the FDA (a federal agency) approved the warning labels, state law claims cannot be brought. 

Our lawyers talked about this in the last update in June – this motion is crucial because the crux of this class action lawsuit is that you knew of this problem with kidney injuries yet you did not change their product, instructions, guidelines, or, most importantly, warn doctors of the risk. 

The Special Master in the MDL likely put this issue to bed in the Prilosec-Nexium class action lawsuit. issued a report to the MDL Judge recommending that this argument be rejected because the defendants cannot show that the FDA would have rejected proposals for stronger warnings about kidney damage. The first bellwether trial in the MDL is set for November.

June 2022: The defendants in the Nexium-Prilosec PPI class action MDL have filed motions for summary judgment in the upcoming bellwether test trials. The primary legal argument in this motion is based on a doctrine called federal preemption. The preemption doctrine holds that victims are blocked from bringing tort lawsuits under state law if there is a federal law that protects the defendants from liability. The Special Master in the MDL recently allowed both parties to submit additional briefing to address how a recently decided case on the preemption issue (In re Fosamax Alendronate Prod. Liab. Lit.) could potentially impact the issues in the Nexium-Prilosec cases. Our lawyers have read the Fosamax case (which rules in favor of defendants on a preemption argument), and in our opinion, it is not applicable to the issues in the PPI cases.

April 2022: There are around 13,500 lawsuits pending in the Nexium-Prilosec PPI class action MDL.  The first trial will be in October.  The hope is that a few trials will set settlement amounts for Nexium kidney lawsuits. But many class action lawsuits – at least lately – have had trials, and the parties still could not agree on a settlement amount for the victims.  So the judge, in this case, wants to keep the pressure on the lawyers.  So if a global settlement is not reached, the MDL Judge has identified a group of 200 cases that the parties will be preparing for trial over the next 16 months.

• These drugs have had a troubled history.  Zantac, which was long considered a great and safe drug, has now been associated with cancer.

Problems with Nexium

Nexium is a controversial drug.  At one point, bone fracture lawsuits were all the rage because there was data suggesting Nexium, particularly the long-term use of Nexium, would cause bone fractures and breaks.  Our lawyers believed many of these lawsuits were meritorious.  But the litigation did not get very far.

Continue Reading